Literature DB >> 7506927

Low-dose ultraviolet-B irradiation depletes human epidermal Langerhans cells.

G M Murphy1, P G Norris, A R Young, M F Corbett, J L Hawk.   

Abstract

We have examined the effects of low-dose monochromatic UVB irradiation (295 +/- 5 nm), biologically equivalent to that generally incident on the skin during a 12-session sun-bed course, on the expression of the CD1a epidermal Langerhans cell surface marker in human skin in vivo. In five subjects, 1.5 minimal erythema doses (MEDs) at 295 nm depleted its expression by 50%. In five further subjects, a single 1.5 MED dose, 1.5 MEDs in 10 equal fractions on alternate days, and a single 1.5 MED dose at one-tenth the previously used irradiance, delivered to separate sites, also led to variable but significant depletion of CD1a expression of around 30-50%. Thus, low-dose UVB irradiation, whether received rapidly or slowly, appears significantly and approximately equally to deplete human epidermal Langerhans cell numbers as measured by CD1a expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506927     DOI: 10.1111/j.1365-2133.1993.tb03330.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  The immunohistochemical effects of a single challenge with an intermediate dose of ultraviolet B on normal human skin.

Authors:  C J van der Vleuten; E J Kroot; E M de Jong; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1996-08       Impact factor: 3.017

2.  Endonasal phototherapy significantly alleviates symptoms of allergic rhinitis, but has a limited impact on the nasal mucosal immune cells.

Authors:  Detlef Brehmer; Michael P Schön
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-03       Impact factor: 2.503

3.  Whole-body UVB irradiation during allogeneic hematopoietic cell transplantation is safe and decreases acute graft-versus-host disease.

Authors:  Marina Kreutz; Sigrid Karrer; Petra Hoffmann; Eva Gottfried; Rolf-Markus Szeimies; Joachim Hahn; Matthias Edinger; Michael Landthaler; Reinhard Andreesen; Miriam Merad; Ernst Holler
Journal:  J Invest Dermatol       Date:  2011-08-18       Impact factor: 8.551

4.  Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques.

Authors:  Leanne M Johnson-Huang; Mayte Suárez-Fariñas; Mary Sullivan-Whalen; Patricia Gilleaudeau; James G Krueger; Michelle A Lowes
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

5.  Gene profiling of narrowband UVB-induced skin injury defines cellular and molecular innate immune responses.

Authors:  Milène Kennedy Crispin; Judilyn Fuentes-Duculan; Nicholas Gulati; Leanne M Johnson-Huang; Tim Lentini; Mary Sullivan-Whalen; Patricia Gilleaudeau; Inna Cueto; Mayte Suárez-Fariñas; Michelle A Lowes; James G Krueger
Journal:  J Invest Dermatol       Date:  2012-11-15       Impact factor: 8.551

6.  Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells.

Authors:  J G Krueger; J T Wolfe; R T Nabeya; V P Vallat; P Gilleaudeau; N S Heftler; L M Austin; A B Gottlieb
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

7.  312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions.

Authors:  M Ozawa; K Ferenczi; T Kikuchi; I Cardinale; L M Austin; T R Coven; L H Burack; J G Krueger
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.